Hypertrichosis-Acromegaloid Facial Appearance SyndromeSymptoms, Doctors, Treatments, Advances & More
Hypertrichosis-Acromegaloid Facial Appearance Syndrome Overview
Learn About Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
OHSU Hospital
Maria Fleseriu is an Endocrinologist practicing medicine in Portland, Oregon. Dr. Fleseriu is rated as an Elite provider by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Acromegaly, Cushing's disease, Cushing's syndrome, Acromegaloid Facial Appearance Syndrome, and Hormone Replacement Therapy (HRT).
Allegheny Endocrinology Associates PC
Murray Gordon is an Endocrinologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Gordon is rated as an Elite provider by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Acromegaly, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaloid Facial Appearance Syndrome, Hormone Replacement Therapy (HRT), and Thyroidectomy.
Andrea Giustina practices practicing medicine in Milan, Italy. Ms. Giustina is rated as an Elite expert by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Acromegaloid Facial Appearance Syndrome, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaly, Hormone Replacement Therapy (HRT), and Thyroidectomy.
Summary: There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central nervous system tumors in childhood. The gene(s) involved in the pathogenesis of these tumors are largely not known; their possible association with other developmental defects or inheritance pattern(s) has not been investigated. The present...
Summary: The primary purpose of this study is to assess the effect of Debio 4126 in the maintenance of the levels of insulin-like growth factor 1 (IGF-1) ≤1x upper limit of normal (ULN) in the double-blind period (Period 1) in comparison to placebo at week 36.